A genome-wide linkage analysis of dementia in the Amish

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 141 B, Issue 2, 2006, Pages 160-166

  Hahs, Daniel W ^a   McCauley, Jacob L ^a   Crunk, Amy E ^a   McFarland, Lynne L ^a   Gaskell, Perry C ^b   Jiang, Lan ^a   Slifer, Susan H ^b   Vance, Jeffery M ^b   Scott, William K ^b   Welsh Bohmer, Kathleen A ^b   Johnson, Stephanie R ^b   Jackson, Charles E ^c   Pericak Vance, Margaret A ^b   Haines, Jonathan L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Alzheimer's Disease; Chromosome 10; Chromosome 4; Microsatellites; Screen

Indexed keywords

ALZHEIMER DISEASE; AMISH; ARTICLE; AUTOSOME; CHROMOSOME 10Q; CHROMOSOME 11P; CHROMOSOME 19P; CHROMOSOME 3Q; CHROMOSOME 4Q; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; NORTH AMERICA; PRIORITY JOURNAL; UNITED STATES;

DEMENTIA; ETHNIC GROUPS; FEMALE; GENOME, HUMAN; GENOTYPE; HUMANS; INDIANA; LINKAGE (GENETICS); LOD SCORE; MALE; MICROSATELLITE REPEATS; OHIO;

EID: 32244436670     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30257     Document Type: Article

References (86)

1. Agarwala R, Schaffer AA, Tomlin JF. 2001. Towards a complete North American Anabaptist Genealogy II: Analysis of inbreeding. Hum Biol 73(4):533-545.
2. Ashley-Koch AE. 2005. An autosomal genomic screen for dementia in an extended Amish family. Neurosci Lett 379(3):199-204.
3. Avramopoulos D, Fallin MD, Bassett SS. 2005. Linkage to chromosome 14q in Alzheimer's disease (AD) patients without psychotic symptoms. Am J Med Genet B Neuropsychiatr Genet 132(1):9-13.
4. Benton A. 1992. Benton visual retention test: 5th edn. New York: Psychological Corporation.
5. Benton A, Sivan A, de Hamsher K. 1994. Multilingual aphasia examination. Iowa City, IA: AJA Associates.
6. Bertram L, et al. 2000. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290(5500):2302-2303.
7. Blacker D, et al. 2003. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12(1):23-32.
8. Blomqvist ME, et al. 2004. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease. Neurosci Lett 358(3):220-222.
9. Brookmeyer R, Gray S, Kawas C. 1998. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88(9):1337-1342.
10. Clark CM, Ewbank DC. 1996. Performance of the dementia severity rating scale: A caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Disord 10(1):31-39.
11. Corder EH, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261(5123):921-923.
12. Cummings JL, et al. 1998. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51: (1 Suppl 1). S2-S17.
13. Epstein MP, Duren WL, Boehnke M. 2000. Improved inference of relationship for pairs of individuals. Am J Hum Genet 67(5):1219-1231.
14. Ertekin-Taner N, et al. 2000. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290(5500):2303-2304.
15. Farrer LA, et al. 2003. Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. Hum Mol Genet 12(4):415-422.
16. Fleminger S, et al. 2003. Head injury as a risk factor for Alzheimer's disease: The evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry 74(7):857-862.
17. Folstein MF, Folstein SE, McHugh PR. 1975. "Mini-Mental State": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
18. Francomano CA, McKusick VA, Biesecker LG. 2003. Medical genetic studies in the Amish: Historical perspective. Am J Med Genet C Semin Med Genet 121(1):1-4.
19. Geldmacher DS, Whitehouse PJ, Jr. 1997. Differential diagnosis of Alzheimer's disease. Neurology 48(5 Suppl 6):S2-S9.
20. Gingerich HF, Kreider RW. 1986. Amish and amish mennonite genealogies. Gordonville, PA: Pequea Publishers.
21. Goate AM, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 33:53-56.
22. Hayden KM, et al. 2003. Characteristics of a two-stage screen for incident dementia. J Clin Epidemiol 56(11):1038-1045.
23. Hiltunen M, et al. 2001. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology 57(9):1663-1668.
24. Holder J, Warren AC. 1998. Prevalence of Alzheimer's disease and apolipoprotein E allele frequencies in the Old Order Amish. J Neuropsychiatry Clin Neurosci 10(1):100-102.
25. Holmans P, et al. 2005. Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 135:24-32.
26. Hostetler J. 1993. Amish society, 4th edn. Baltimore, MD: Johns hopkins University Press.
27. Hughes CP, et al. 1982. A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
28. Jackson CE, et al. 1968. Consanguinity and blood group distribution in an Amish isolate. Am J Hum Genet 20(6):522-527.
29. Jamison C, Scogin F. 1992. Development of an interview-based geriatric depression rating scale. Int J Aging Hum Dev 35(3):193-204.
30. Jastak S, Wilkinson GS. 1984. Wide range achievement test -Revised. Wilmington, Delaware: Jastak Associates.
31. Johnson CC, et al. 1993. Prevalence of Dementia in the Amish: A three county servey. Am J Epidemiol 138:645.
32. Johnson CC, et al. 1997. Cognitive impairment in the Amish: A four county survey. Int J Epidemiol 26:387-394.
33. Kaplan E, Goodglass H, Weintraub S. 1976. The Boston naming test. Philadelphia, PA: Lea & Febiger.
34. Kehoe P, et al. 1999. A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8(2):237-245.
35. Khachaturian AS, Gallo JJ, Breitner JC. 2000. Performance characteristics of a two-stage dementia screen in a population sample. J Clin Epidemiol 53(5):531-540.
36. Kraybill DB. 2001. The riddle of amish culture. Baltimore, MD: Johns Hopkins University Press.
37. Levy-Lahad E, et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
38. Li YJ, et al. 2002. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70(4):985-993.
39. Li YJ, et al. 2003. Glutathione S-Transferase Omega 1 modifies age-at-onset of Alzheimer Disease and Parkinson Disease. Hum Mol Genet 12(24): 3259-3267.
40. Mattis S. 1976. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, editors. Geriatric Psychiatry. New Your, NY: Grune & Stratton.
41. Mayeux R, et al. 2002. Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics. Am J Hum Genet 70(1):237-243.
42. McKusick VA. 1978. Medical genetic studies of the amish: Selected papers. Baltimore, MD: Johns Hopkins University Press.
43. Menzel H-J, Kladetzky RG, Asman G. 1983. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis 3:310-315.
44. Morris JC, et al. 1989. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39(9):1159-1165.
45. Morse JK, et al. 1993. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 13(10):4146-4156.
46. Myers A, et al. 2000a. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290(5500):2304-2305.
47. Myers A, et al. 2002. Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 114(2):235-244.
48. Myers AJ, Goate AM, Holmans P, Williams J, Owen MJ, Crook R, Wavrant-De VF, Hardy JA. 2000b. Susceptibility locus for late-onset Alzheimer's disease on chromosome 10. Washington, DC:.
49. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63(1): 259-266.
50. Oldfield RC. 1971. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia 9(1):97-113.
51. Pericak-Vance MA, et al. 1988. Genetic linkage studies in Alzheimer's disease families. Exp Neurol 102(3):271-279.
52. Pericak-Vance MA, et al. 1991. Linkage studies in familial Alzheimer's disease: Evidence for chromosome 19 linkage. Am J Hum Genet 48: 1034-1050.
53. Pericak-Vance MA, et al. 1996. Alzheimer's disease and apolipoprotein E-4 allele in an Amish population. Ann Neurol 39(6):700-704.
54. Pericak-Vance MA, et al. 1997. Complete genomic screen in late-onset familial Alzheimer disease: Evidence for a new locus on chromosome 12. JAMA 278(15):1237-1241.
55. Pericak-Vance MA, et al. 1998. Complete genomic screen in late-onset familial Alzheimer's disease. Neurobiol Aging 19:(1 Suppl). S39-S42.
56. Pericak-Vance MA, et al. 2000. Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 35(9-10):1343-1352.
57. Phillips HS, et al. 1991. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7(5):695-702.
58. Pola R, et al. 2003. Intercellular adhesion molecule-1 K469E gene polymorphism and Alzheimer's disease. Neurobiol Aging 24(2):385-387.
59. Pringle AK, et al. 1996. Brain-derived neurotrophic factor, but not neurotrophin-3, prevents ischaemia-induced neuronal cell death in organotypic rat hippocampal slice cultures. Neurosci Lett 211(3):203-206.
60. Reitan R. 1958. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills (8):271-276.
61. Riemenschneider M, et al. 2002. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele. Mol Psychiatry 7(7):782-785.
62. Rocca WA, et al. 1991. Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol 30(3):381-390.
63. Rogaev EI, et al. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376(6543):775-778.
64. Rogaeva E, et al. 1998. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 280(7):614-618.
65. Roses AD, Pericak-Vance MA. 1997. Alzheimer's disease and other dementias. In: Connon JM, editor. Emery and Rimoin's principles and practice of medical genetics. New York: Churchill Livingston Publishing Co.
66. Saunders AM, et al. 1993. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472.
67. Schellenberg GD, et al. 1992. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258(5082):668-671.
68. Schellenberg GD, D'Souza I, Poorkaj P. 2000. The genetics of Alzheimer's disease. Curr Psychiatry Rep 2(2):158-164.
69. Scott WK. 2000. Fine mapping of the chromosome 12 late-onset alzheimer disease locus: Potential genetic and phenotypic heterogeneity. Am J Hum Genet 66(3):922-932.
70. Scott WK, et al. 2003. Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet 73(5): 1041-1051.
71. Sherrington R, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
72. Shipley W. 1967. Shipley institute of living scale. Los Angeles: Western Psychological Services.
73. Smith A. 1973. Symbol digit modalities test. Los Angeles: Western Psychological Services.
74. Sobel E, Lange K. 1996. Descent graphs in pedigree analysis: Applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 58(6):1323-1337.
75. St. George-Hyslop PH, et al. 1987. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 235:885-890.
76. St George-Hyslop P, et al. 1992. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet 2:330-334.
77. Strittmatter WJ, Roses AD. 1995. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 92:4725-4727.
78. Teng EL, Chui HC. 1987. The modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48(8):314-318.
79. Tschanz JT, et al. 2000. Dementia diagnoses from clinical and neuropsychological data compared: The Cache County study. Neurology 54(6):1290-1296.
80. Tschanz JT, et al. 2002. An adaptation of the modified mini-mental state examination: Analysis of demographic influences and normative data: The cache county study. Neuropsychiatry Neuropsychol Behav Neurol 15(1):28-38.
81. Van Broeckhoven C, et al. 1992. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nat Genet 2(4):335-339.
82. Vance JM, Othmane KB. 1998. Methods of genotyping: Design and implementation of mapping studies ofr complex human diseases. In: Haines JL, Pericak-Vance MA, editors. Current protocols in human genetics. New York: John Wiley & Sons, Inc., New York.
83. Wechsler D. 1987. Wechsler memory scale - Revised. New York: Psychological Corporation.
84. Wijsman EM, et al. 2004. Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet 75(3):398-409.
85. Zubenko GS, et al. 1998a. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution. Genomics 50(2):121-128.
86. Zubenko GS, et al. 1998b. Initial results of a genome survey for novel Alzheimer's disease risk genes: Association with a locus on the X chromosome. Am J Med Genet 81(2):196-205.